Form 4: IGM Biosciences CFO Misbah Tahir Reports Acquisition and Disposal of Shares and Stock Options
SEC Form 4
CFO of IGM Biosciences, Misbah Tahir, reports acquiring restricted stock units and stock options while disposing of common stock.
Summary
- Misbah Tahir, CFO of IGM Biosciences, filed a Form 4 detailing changes in beneficial ownership.
- On March 12, 2024, Tahir acquired 46,250 restricted stock units (RSUs) at a price of $0.
- Each RSU represents a contingent right to receive one share of IGM Biosciences' common stock, vesting in installments starting June 12, 2024.
- Also on March 12, 2024, Tahir acquired 92,500 stock options with an exercise price of $9.95, vesting in monthly installments starting April 12, 2024, and expiring on March 12, 2034.
- Tahir disposed of 95,858 shares of common stock.
- Following these transactions, Tahir beneficially owns 92,500 derivative securities.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing, so the sentiment is neutral. It simply reports transactions by a company insider.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 03/12/2024 | Date of earliest transaction: acquisition of RSUs and stock options, disposal of common stock. |
| 06/12/2024 | First vesting date for RSUs (one-sixteenth). |
| 04/12/2024 | First vesting date for stock options (one-forty-eighth). |
| 03/12/2034 | Expiration date for stock options. |
| 03/14/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.